Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

Overview of attention for article published in Obstetrical and Gynecological Survey, June 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 113 followers.

Most Popular: Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer: (Abstracted from N En... https://t.co/Qz28gLrK5Z

New Article: Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer: (Abstracted from N Eng... https://t.co/Qz28gLrK5Z

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.